Hybrid Closed Loop Therapy
A New Era Of Precision And Convenience
Technological innovations have ushered in a new era of precision and convenience when it comes to Type 1 diabetes management. Among the most groundbreaking advances is the Hybrid Closed Loop Therapy System, a game-changing approach that integrates continuous glucose monitoring with insulin delivery. This seamless partnership represents a monumental stride in the pursuit of balanced glucose levels.
At Advanced Therapeutics, we’re here to explain what the Hybrid Closed Loop Therapy System means for individuals living with Type 1 diabetes.
A Closer Look At Hybrid Closed Loop Therapy
At its essence, the Hybrid Closed Loop Therapy System is a technological marvel designed to empower individuals with Type 1 diabetes. This system combines continuous glucose monitoring with insulin delivery, creating a dynamic feedback loop that operates in real time. It leverages data from the glucose monitor to make instantaneous adjustments in insulin delivery, providing an unprecedented level of accuracy and control. This means fewer peaks and troughs in glucose levels, leading to improved overall well-being.
One of the most significant advantages of the Hybrid Closed Loop Therapy System lies in its automation. Unlike traditional Type 1 diabetes management methods, where individuals manually calculate and administer insulin doses, this system takes on the task with minimal intervention. The artificial pancreas algorithms constantly analyse glucose data, ensuring that insulin delivery aligns seamlessly with the body’s needs. This not only reduces the cognitive load on individuals but also leads to more stable and predictable glucose levels.
Enhancing Quality Of Life For Those With Type 1 Diabetes
For those living with Type 1 diabetes, Hybrid Closed Loop Therapy can be a game-changer. It provides a level of freedom and confidence that was once unimaginable. No longer bound by the constant worry of fluctuating glucose levels, individuals can engage in daily activities, exercise and even enjoy meals with a newfound sense of ease.
The system’s ability to adapt to changing circumstances means that it can support individuals through various situations, offering peace of mind and improved quality of life. With over 15 years of clinical studies and huge amounts of data, at Advanced Therapeutics (UK) Ltd, we’re able to offer Hybrid Closed Loop Therapy alongside a state-of-the-art pump.
The Dana i System
At the forefront of this revolution stands the Dana i System, an Alternate Controller Enabled (ACE) pump. Its incorporation of low-energy Bluetooth technology enables seamless connectivity with smartphones and other Bluetooth-enabled devices. This establishes a vital link through which artificial pancreas algorithms communicate with the pump, ensuring precise and timely insulin delivery. The Dana i System represents a beacon of hope for individuals with Type 1 diabetes, offering a path to a more balanced and fulfilling life.
Dana CamAPS® FX
Dana CamAPS® FX is a system that adjusts insulin delivery based on your glucose levels. It’s CE-marked and works with Android™, allowing you to customise your settings with ease. It even holds a special licence, allowing it to be used during pregnancy and for children aged 1-6. Trials show better glucose control and lower HbA1c levels, outperforming other therapies. It offers a more stable future for those who would’ve otherwise used insulin pens and finger pricks to monitor their Type 1 diabetes.
What is the Hybrid Closed Loop System?
It combines continuous glucose monitoring with insulin delivery in real-time, ensuring more stable glucose levels.
How does Hybrid Closed Loop Therapy enhance daily life for individuals with Type 1 diabetes?
Automated insulin delivery adapts to changing circumstances, offering unprecedented freedom and confidence for improved quality of life.
What is the Dana Diabecare i System and what role does it play?
The Dana Diabecare i System is a Bluetooth-enabled insulin pump, which plays a vital role in precise insulin delivery, paving the way for a more balanced life.
Can you tell me about Dana CamAPS® FX and its benefits?
Dana CamAPS® FX adjusts insulin delivery based on glucose levels, providing customisable settings on Android™. With a special licence for pregnancy and ages 1-6, it ensures improved glucose control, offering a stable future for Type 1 diabetes management.
The Future Of Type 1 Diabetes Management
Hybrid Closed Loop Therapy represents a monumental leap in Type 1 diabetes care, revolutionising how individuals manage their condition. By integrating continuous glucose monitoring with insulin delivery, this technology offers a level of precision and control that was once beyond imagination. For those living with Type 1 diabetes, this means newfound freedom and confidence in navigating daily life. With the Dana Diabecare i System leading the way, the future of Type 1 diabetes management looks brighter than ever before. Embracing this technology is not just a step forward; it’s a step towards a healthier, more vibrant future for individuals with Type 1 diabetes worldwide.